Results 181 to 190 of about 1,264,620 (412)
A CASE OF LYMPHOMA AFFECTING THE LARYNX, EYELID, AND CEREBRAL MEMBRANES. [PDF]
, 1887 E.Clifford Beale
openalex +1 more source
Nanomedicine for the Treatment of Non-Hodgkin Lymphoma [PDF]
, 2019 Non-Hodgkin lymphoma, or NHL, is the predominant category of lymphoma. NHL is a type of lymphoid hematopoietic malignancy which approximately 70,000 Americans are diagnosed with annually, with the number of diagnoses growing annually.
Gandhi, B.Pharm, Tanvi
core +1 more source
Advanced Synthesis &Catalysis, EarlyView.Abstract The demonstrated light‐initiated addition of radicals formed on an active methylene group to styrene derivatives exhibits a product selectivity influenced by the presence of a protic solvent. Under protic conditions, the predominant products are branched compounds with the alkene moiety attached to the methylene group.
Małgorzata Pałyga +2 more
wiley +1 more source
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
American Journal of Hematology, Volume 98, Issue 1, Page 193-209, January 2023., 2023 Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). Diagnosis The diagnosis of MF or SS requires the integration of clinical and histopathologic data.
Alexandra C. Hristov +2 more
wiley +1 more source
P072: Impact of Ageing on the Survivorship Experiences of Patients with Hodgkin Lymphoma
HemaSphere, 2022 Cherie Bates +2 more
doaj +1 more source
Mathematical model of CAR-T-cell therapy for a B-cell Lymphoma lymph node [PDF]
arXivCAR-T cell therapies have demonstrated significant success in treating B-cell leukemia in children and young adults. However, their effectiveness in treating B-cell lymphomas has been limited. Unlike leukemia, lymphoma often manifests as solid masses of cancer cells in lymph nodes, glands, or organs, making these tumors harder to access thus hindering ...
arxiv
CD40 Ligand Rescues Inhibitor of Differentiation 3-Mediated G1Arrest Induced by Anti-IgM in WEHI-231 B Lymphoma Cells [PDF]
, 1923 Kikumi Hata +2 more
openalex +1 more source
Inhalable Hsa‐miR‐30a‐3p Liposomes Attenuate Pulmonary Fibrosis
Advanced Science, EarlyView.The study explores inhalable hsa‐miR‐30a‐3p‐loaded liposomes as a treatment for bleomycin‐induced pulmonary fibrosis in mice. Hsa‐miR‐30a‐3p is electroporated into liposomes and formulated into a dry powder for inhalation. Delivered via dry powder inhalation, it improves pulmonary function, promotes myofibroblast de‐differentiation by targeting CNPY2 ...
Shuo Liu +14 more
wiley +1 more source
American Journal of Hematology, Volume 98, Issue 1, Page 180-192, January 2023., 2023 Abstract Direct comparisons of the effectiveness of the numerous novel therapies in the diffuse large B‐cell lymphoma (DLBCL) treatment landscape in a range of head‐to‐head randomized phase 3 trials would be time‐consuming and costly. Comparative effectiveness studies using real‐world data (RWD) represent a complementary approach.
Grzegorz Nowakowski +4 more
wiley +1 more source